| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2478075 | Annales Pharmaceutiques Françaises | 2013 | 4 Pages |
Abstract
In order to alleviate the inherent uncertainty that comes with the market access and public funding of new health products, a conditional reimbursement mechanism is proposed. The latter is circumscribed by recommendations regarding its implementation in limited cases in order to allow for a fair access of patients to therapeutic innovations, within economic conditions both optimum and reviewable.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
J.-N. Bail,